Experience and future perspectives on the use of the Papanicolaou Society of Cytopathology Terminology System for reporting pancreaticobiliary cytology
The Papanicolaou Society of Cytopathology developed a set of guidelines for reporting pancreaticobiliary cytology in 2014 (PB System), with a six‐tiered system: Nondiagnostic, Negative, Atypical, Neoplastic (Benign or Other), Suspicious, and Positive. This proposed scheme incorporates ancillary test...
Gespeichert in:
Veröffentlicht in: | Diagnostic cytopathology 2020-05, Vol.48 (5), p.494-498 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 498 |
---|---|
container_issue | 5 |
container_start_page | 494 |
container_title | Diagnostic cytopathology |
container_volume | 48 |
creator | Saieg, Mauro Pitman, Martha B. |
description | The Papanicolaou Society of Cytopathology developed a set of guidelines for reporting pancreaticobiliary cytology in 2014 (PB System), with a six‐tiered system: Nondiagnostic, Negative, Atypical, Neoplastic (Benign or Other), Suspicious, and Positive. This proposed scheme incorporates ancillary testing such as biochemical testing of cyst fluids for diagnosis and provides terminology that standardizes the category of the various diseases of the pancreas, some of which are difficult to diagnose specifically by cytology alone. Since its initial publication five and half years ago, several groups have published their experiences on the use of the PB System and have shown that most objectives proposed by the original publication have been achieved. They have shown that there is a better understanding and definition of the diagnostic categories with an associated distribution and risk of malignancy. The diagnostic categories of Neoplastic: Other, Suspicious, and Malignant show a high sensitivity and specificity for the diagnosis of malignancy. The System also provides a multi‐specialist view of pancreatic lesions, with biochemical and radiological findings being incorporated into the final pathological report. The present review summarizes these findings and discusses the future perspectives and foreseen changes that are to be incorporated to a second edition of the reporting System. |
doi_str_mv | 10.1002/dc.24393 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2385131083</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2352634901</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3493-29ae75cddd1731ec7c60476fc9bcfec8d68804ece3e8e744ee10e575558bffde3</originalsourceid><addsrcrecordid>eNqNkVtrFjEQhoMo9rMK_gIJeCPI1mSzx0tZ6wEKCq3XS3Z20qbsl6xJtrq_xL_rfAcrCIJXGZJn3nkzL2PPpTiTQuRvRjjLC9WqB2wjRVtnQqn2Ids0dVlmUqj2hD2J8VYI0eayesxOVC6UVCrfsJ_nP2YMFh0g127kZklLQE53cUZI9g4j946nG-RLRO7NvvyiZ-0s-En7hV96sJjW3Vu3Jj_rdOMnf73yKwxb6w715RoTbrnxgQecfUjWXXMSgYA6kdJgJ6vDyoEUdg1P2SOjp4jPjucp-_r-_Kr7mF18_vCpe3uRgSpaleWtxrqEcRxlrSRCDZUo6spAO4BBaMaqaUSBgAobrIsCUQosaS1lMxgzojplrw66c_DfFoyp39oIOE3aoV9in6syr2iUkIS-_Au99Utw5I6oppRKikb9EYTgYwxo-jnYLX2tl6LfhdWP0O_DIvTFUXAZtjjeg7_TIeD1AfiOgzcR9jHdYxRnmSviSJXsEd38P93ZRHv3rvOLS9SaHVvthOs_HffvuoPzX-11wZ0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2385131083</pqid></control><display><type>article</type><title>Experience and future perspectives on the use of the Papanicolaou Society of Cytopathology Terminology System for reporting pancreaticobiliary cytology</title><source>Access via Wiley Online Library</source><source>Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><creator>Saieg, Mauro ; Pitman, Martha B.</creator><creatorcontrib>Saieg, Mauro ; Pitman, Martha B.</creatorcontrib><description>The Papanicolaou Society of Cytopathology developed a set of guidelines for reporting pancreaticobiliary cytology in 2014 (PB System), with a six‐tiered system: Nondiagnostic, Negative, Atypical, Neoplastic (Benign or Other), Suspicious, and Positive. This proposed scheme incorporates ancillary testing such as biochemical testing of cyst fluids for diagnosis and provides terminology that standardizes the category of the various diseases of the pancreas, some of which are difficult to diagnose specifically by cytology alone. Since its initial publication five and half years ago, several groups have published their experiences on the use of the PB System and have shown that most objectives proposed by the original publication have been achieved. They have shown that there is a better understanding and definition of the diagnostic categories with an associated distribution and risk of malignancy. The diagnostic categories of Neoplastic: Other, Suspicious, and Malignant show a high sensitivity and specificity for the diagnosis of malignancy. The System also provides a multi‐specialist view of pancreatic lesions, with biochemical and radiological findings being incorporated into the final pathological report. The present review summarizes these findings and discusses the future perspectives and foreseen changes that are to be incorporated to a second edition of the reporting System.</description><identifier>ISSN: 8755-1039</identifier><identifier>EISSN: 1097-0339</identifier><identifier>DOI: 10.1002/dc.24393</identifier><identifier>PMID: 32031332</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Cellular biology ; cytology ; Life Sciences & Biomedicine ; Medical Laboratory Technology ; Pancreatic cancer ; pancreaticobiliary ; Papanicolaou Society ; Pathology ; Science & Technology ; terminology</subject><ispartof>Diagnostic cytopathology, 2020-05, Vol.48 (5), p.494-498</ispartof><rights>2020 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>9</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000523332100013</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c3493-29ae75cddd1731ec7c60476fc9bcfec8d68804ece3e8e744ee10e575558bffde3</citedby><cites>FETCH-LOGICAL-c3493-29ae75cddd1731ec7c60476fc9bcfec8d68804ece3e8e744ee10e575558bffde3</cites><orcidid>0000-0002-9438-226X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fdc.24393$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fdc.24393$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27933,27934,28257,45583,45584</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32031332$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saieg, Mauro</creatorcontrib><creatorcontrib>Pitman, Martha B.</creatorcontrib><title>Experience and future perspectives on the use of the Papanicolaou Society of Cytopathology Terminology System for reporting pancreaticobiliary cytology</title><title>Diagnostic cytopathology</title><addtitle>DIAGN CYTOPATHOL</addtitle><addtitle>Diagn Cytopathol</addtitle><description>The Papanicolaou Society of Cytopathology developed a set of guidelines for reporting pancreaticobiliary cytology in 2014 (PB System), with a six‐tiered system: Nondiagnostic, Negative, Atypical, Neoplastic (Benign or Other), Suspicious, and Positive. This proposed scheme incorporates ancillary testing such as biochemical testing of cyst fluids for diagnosis and provides terminology that standardizes the category of the various diseases of the pancreas, some of which are difficult to diagnose specifically by cytology alone. Since its initial publication five and half years ago, several groups have published their experiences on the use of the PB System and have shown that most objectives proposed by the original publication have been achieved. They have shown that there is a better understanding and definition of the diagnostic categories with an associated distribution and risk of malignancy. The diagnostic categories of Neoplastic: Other, Suspicious, and Malignant show a high sensitivity and specificity for the diagnosis of malignancy. The System also provides a multi‐specialist view of pancreatic lesions, with biochemical and radiological findings being incorporated into the final pathological report. The present review summarizes these findings and discusses the future perspectives and foreseen changes that are to be incorporated to a second edition of the reporting System.</description><subject>Cellular biology</subject><subject>cytology</subject><subject>Life Sciences & Biomedicine</subject><subject>Medical Laboratory Technology</subject><subject>Pancreatic cancer</subject><subject>pancreaticobiliary</subject><subject>Papanicolaou Society</subject><subject>Pathology</subject><subject>Science & Technology</subject><subject>terminology</subject><issn>8755-1039</issn><issn>1097-0339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><recordid>eNqNkVtrFjEQhoMo9rMK_gIJeCPI1mSzx0tZ6wEKCq3XS3Z20qbsl6xJtrq_xL_rfAcrCIJXGZJn3nkzL2PPpTiTQuRvRjjLC9WqB2wjRVtnQqn2Ids0dVlmUqj2hD2J8VYI0eayesxOVC6UVCrfsJ_nP2YMFh0g127kZklLQE53cUZI9g4j946nG-RLRO7NvvyiZ-0s-En7hV96sJjW3Vu3Jj_rdOMnf73yKwxb6w715RoTbrnxgQecfUjWXXMSgYA6kdJgJ6vDyoEUdg1P2SOjp4jPjucp-_r-_Kr7mF18_vCpe3uRgSpaleWtxrqEcRxlrSRCDZUo6spAO4BBaMaqaUSBgAobrIsCUQosaS1lMxgzojplrw66c_DfFoyp39oIOE3aoV9in6syr2iUkIS-_Au99Utw5I6oppRKikb9EYTgYwxo-jnYLX2tl6LfhdWP0O_DIvTFUXAZtjjeg7_TIeD1AfiOgzcR9jHdYxRnmSviSJXsEd38P93ZRHv3rvOLS9SaHVvthOs_HffvuoPzX-11wZ0</recordid><startdate>202005</startdate><enddate>202005</enddate><creator>Saieg, Mauro</creator><creator>Pitman, Martha B.</creator><general>John Wiley & Sons, Inc</general><general>Wiley</general><general>Wiley Subscription Services, Inc</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9438-226X</orcidid></search><sort><creationdate>202005</creationdate><title>Experience and future perspectives on the use of the Papanicolaou Society of Cytopathology Terminology System for reporting pancreaticobiliary cytology</title><author>Saieg, Mauro ; Pitman, Martha B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3493-29ae75cddd1731ec7c60476fc9bcfec8d68804ece3e8e744ee10e575558bffde3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cellular biology</topic><topic>cytology</topic><topic>Life Sciences & Biomedicine</topic><topic>Medical Laboratory Technology</topic><topic>Pancreatic cancer</topic><topic>pancreaticobiliary</topic><topic>Papanicolaou Society</topic><topic>Pathology</topic><topic>Science & Technology</topic><topic>terminology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saieg, Mauro</creatorcontrib><creatorcontrib>Pitman, Martha B.</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Diagnostic cytopathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saieg, Mauro</au><au>Pitman, Martha B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Experience and future perspectives on the use of the Papanicolaou Society of Cytopathology Terminology System for reporting pancreaticobiliary cytology</atitle><jtitle>Diagnostic cytopathology</jtitle><stitle>DIAGN CYTOPATHOL</stitle><addtitle>Diagn Cytopathol</addtitle><date>2020-05</date><risdate>2020</risdate><volume>48</volume><issue>5</issue><spage>494</spage><epage>498</epage><pages>494-498</pages><issn>8755-1039</issn><eissn>1097-0339</eissn><abstract>The Papanicolaou Society of Cytopathology developed a set of guidelines for reporting pancreaticobiliary cytology in 2014 (PB System), with a six‐tiered system: Nondiagnostic, Negative, Atypical, Neoplastic (Benign or Other), Suspicious, and Positive. This proposed scheme incorporates ancillary testing such as biochemical testing of cyst fluids for diagnosis and provides terminology that standardizes the category of the various diseases of the pancreas, some of which are difficult to diagnose specifically by cytology alone. Since its initial publication five and half years ago, several groups have published their experiences on the use of the PB System and have shown that most objectives proposed by the original publication have been achieved. They have shown that there is a better understanding and definition of the diagnostic categories with an associated distribution and risk of malignancy. The diagnostic categories of Neoplastic: Other, Suspicious, and Malignant show a high sensitivity and specificity for the diagnosis of malignancy. The System also provides a multi‐specialist view of pancreatic lesions, with biochemical and radiological findings being incorporated into the final pathological report. The present review summarizes these findings and discusses the future perspectives and foreseen changes that are to be incorporated to a second edition of the reporting System.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>32031332</pmid><doi>10.1002/dc.24393</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-9438-226X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 8755-1039 |
ispartof | Diagnostic cytopathology, 2020-05, Vol.48 (5), p.494-498 |
issn | 8755-1039 1097-0339 |
language | eng |
recordid | cdi_proquest_journals_2385131083 |
source | Access via Wiley Online Library; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /> |
subjects | Cellular biology cytology Life Sciences & Biomedicine Medical Laboratory Technology Pancreatic cancer pancreaticobiliary Papanicolaou Society Pathology Science & Technology terminology |
title | Experience and future perspectives on the use of the Papanicolaou Society of Cytopathology Terminology System for reporting pancreaticobiliary cytology |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T03%3A09%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Experience%20and%20future%20perspectives%20on%20the%20use%20of%20the%20Papanicolaou%20Society%20of%20Cytopathology%20Terminology%20System%20for%20reporting%20pancreaticobiliary%20cytology&rft.jtitle=Diagnostic%20cytopathology&rft.au=Saieg,%20Mauro&rft.date=2020-05&rft.volume=48&rft.issue=5&rft.spage=494&rft.epage=498&rft.pages=494-498&rft.issn=8755-1039&rft.eissn=1097-0339&rft_id=info:doi/10.1002/dc.24393&rft_dat=%3Cproquest_cross%3E2352634901%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2385131083&rft_id=info:pmid/32031332&rfr_iscdi=true |